Obaob, Emelyn C.
HRN: 28-41-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/13/2026
CEFTRIAXONE 1G (VIAL)
01/13/2026
01/20/2026
IV
2gm
OD
Lacerated Wound
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes